 The advance in nanotechnology has opened up new therapeutic horizons for silver and interactions between viral biomolecules and silver nanoparticles suggests that nanosystems may enhance current prevention of infection and antiviral therapies. Recent studies have demonstrated the mechanism of antiviral action of silver nanoparticles on HIV and their ability to inhibit the transmission of HIV-1 infection in human cervix-organ culture. But the interaction of AGNPs with viruses is largely unexplored. This article was authored by Ixtapanturant Liliana, Garza Trevino Elsa N, Lara Umbato H, and others.